紧急肝脏再移植与边际捐赠者
María Josefa Cuevas López1, Carmen Bernal Bellido1, Carmen Cepeda Franco1
1Virgen del Rocio University Hospital, Seville, Spain.
Transplantation proceedings
|November 16, 2023
概括
使用边际捐赠者进行紧急肝脏再移植是安全的. 这项研究发现,与理想捐赠者相比,并发症或生存率没有显著差异,这支持他们在关键病例中使用它们.
科学领域:
- 移植手术 移植手术
- 肝病学 肝病学是一种肝病学.
- 器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器
背景情况:
- 紧急肝脏再移植是有限的供体可用性的关键程序.
- 越来越多地考虑边际捐赠者,通常是老年人或患有并发病的人.
- 使用边际供体对再移植结果的影响需要调查.
研究的目的:
- 评估利用边际捐赠者用于紧急肝脏再移植的安全性和有效性.
- 为了比较从边缘与理想捐赠者接收移植的受体之间的结果.
主要方法:
- 紧急肝脏再移植 (1990-2021) 的回顾性病例控制研究.
- 患者被分为两组:对照组 (理想捐赠者) 和病例组 (边际捐赠者).
- 分析包括捐赠者/接受者的人口统计数据,并发症和生存率.
主要成果:
- 边际捐赠者年龄大得多 (平均年龄为71岁与58岁).
- 在接受者人口统计学,并发症,MELD得分或再移植原因方面没有显著差异.
- 早期术后死亡率和短期至中期存活率在两组之间没有统计学上显著的差异.
结论:
- 在紧急肝脏再移植中使用边际供体是安全的.
- 没有观察到并发症增加或短期到中期存活时间受损.
- 边际捐赠者代表了一种可行的选择,以改善移植移植的移植可用性.
更多相关视频
11:26Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies
Published on: March 8, 2024
403
16:19Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
Published on: September 13, 2014
12.8K
相关概念视频
Kidney Transplant I: Introduction
14
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
14
Kidney Transplant II: Surgical Procedure
20
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
20
